Our take
Mako is the market's reference orthopedic robot. The fourth generation Mako 4 runs total knee, total hip, partial knee, spine, and shoulder applications on one system, and Stryker reports more than two million robotic procedures.1,2
The tradeoff is lock-in. Mako's knee application is built around Stryker's Triathlon implants, and Stryker publishes no price.1
Scores by criterion
Pricing transparency, 3.0: Stryker publishes no price for Mako or its applications.1
Product maturity, 9.0: Mako 4 is the fourth generation system and runs total hip, total knee, partial knee, spine, and shoulder applications, integrated with Stryker's Q Guidance System.1
Deployment evidence, 9.5: Stryker says Mako is available in more than 45 countries and has performed more than two million robotic procedures.2
Company durability, 9.5: Stryker reported 2025 net sales of 25.1 billion dollars, up 11.2%.3
Ease of integration, 6.5: Mako uses CT-based planning and a small operating room footprint, but its knee workflow is designed around Stryker's own Triathlon components.1
Each criterion is defined on our methodology page.
Who uses Mako and what it's for
The buyer is a hospital or surgery center doing high volumes of knee and hip replacement with Stryker implants that wants one robot for joints, spine, and shoulder.1
Mako 4 and its applications
Mako 4 combines 3D CT-based planning with AccuStop haptic technology, and its Q Guidance System hub also runs cranial and spine guidance software. Stryker's FP8000 camera has a wide field of view for probes and arrays.1
Pricing
Stryker sells Mako by quote. Buyers should price the system, each application, CT planning, and service, and check implant commitments.1
Competitive landscape
| Company | Product | Pricing model | Deployment evidence | Where Mako wins or loses |
|---|---|---|---|---|
| Stryker Mako SmartRobotics | Mako 4 with CT planning and AccuStop haptics1 | Quote; no prices published1 | More than two million procedures in more than 45 countries2 | Market reference; tied to Stryker implants |
| TINAVI | TiRobot II for spine, trauma, and joint surgery10 | Quote; no prices published10 | More than 180,000 cases at more than 200 hospitals4 | TINAVI wins on one robot for spine, trauma, and joint cases. Mako wins on the largest base of robotic joint procedures. |
| Globus Medical ExcelsiusGPS | Rigid arm plus full navigation, CT or fluoroscopy7 | Quote; spec sheet by request7 | 141.0 million dollars of enabling technology sales in 20256 | ExcelsiusGPS wins on rigid trajectory guidance with flexible imaging. Mako wins on the largest base of robotic joint procedures. |
| THINK Surgical TMINI | Handheld, wireless knee robot with TPLAN planning8 | Quote; demo by request8 | 5,000 procedures by May 20268 | TMINI wins on a small knee robot open to many implants. Mako wins on the largest base of robotic joint procedures. |
| eCential Robotics | Imaging, navigation, and robotics in one platform9 | Quote; demo by request9 | More than 3,500 surgeries9 | eCential wins on built-in 3D imaging with any brand of screw. Mako wins on the largest base of robotic joint procedures. |
| Curexo | CUVIS-joint fully automatic knee robot, CUVIS-spine navigation, MorningWalk11 | Quote11 | More than 100 CUVIS-joint installs; Korea, India, US, Australia launches12 | Curexo wins on fully automatic bone cutting on an open implant platform. Mako wins on the largest installed base in knee and hip replacement. |
Limits
No published price.1
Knee workflow built around Stryker Triathlon implants.1
Requires CT-based planning.1
What customers say
Where it helps
More than two million Mako robotic procedures to date.2
Where it falls short
Stryker gives no price or service terms publicly.1
Company backing
Stryker reported 2025 net sales of 25.1 billion dollars, far above the range for our full reviews, so this page is scoped to Mako SmartRobotics.3
Sources
- Stryker, Mako SmartRobotics overview, accessed November 9, 2026
- Stryker, 2025 Comprehensive Report, accessed November 9, 2026
- Stryker, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- TINAVI, About TINAVI, accessed November 9, 2026
- Eastmoney (China Securities Journal), TINAVI 2025 total operating revenue 279 million yuan, up 55.9%, April 29, 2026, accessed November 9, 2026
- Globus Medical, fourth quarter and full year 2025 results, SEC Form 8-K exhibit 99.1, accessed November 9, 2026
- Globus Medical, ExcelsiusGPS product page, accessed November 9, 2026
- THINK Surgical, homepage and news, accessed November 9, 2026
- eCential Robotics, homepage, accessed November 9, 2026
- TINAVI, TiRobot II product page, accessed November 9, 2026
- Curexo, CUVIS-joint, accessed November 13, 2026
- Curexo, History, accessed November 13, 2026
- Curexo, 2025 business report filed with the Korea Exchange (March 17, 2026), accessed November 13, 2026

